Skip to main content
. 2021 Nov 2;15:4503–4525. doi: 10.2147/DDDT.S327378

Table 1.

Summary of Studies on Curcumin with Anti-Inflammatory Effect

Compounds Experimental Models Dosage and Administration Effects Ref
Curcumin LPS-induced BV2 cells 1, 5, and 10μM ↓ NO, IL-1β, IL-6, iNOS
↑ IL-4, IL-10, Arg-1
promoted microglial polarization to the M2 phenotype
[8]
Curcumin Subarachnoid hemorrhage mice models 100mg/kg, i.p. ↓ IL-1β, IL-6, iNOS, and TNF-α, CD86 protein,
↑ IL-10, TGF-β
↓ TLR4 signaling
[9]
Curcumin Cigarette smoke extract-treated Beas-2B cells 2.5, 5 and 7.5μM ↑ PPAR-γ,
↓ NF-κB
[11]
Curcumin Cigarette smoke-induced COPD rat models 100mg/kg, i.g. ↑ PPAR-γ,
↓ NF-κB, inflammation score
↓TNF-α, IL-6
[11]
Curcumin Gp120-induced BV2 cells 10 μM ↓ MCP-1, IL-17 [17]
Curcumin LPS-induced inflammation in vascular smooth muscle cells 5, 10, 30 μmol/L for 24 h ↓ MCP-1, TNF-α, iNOS, NO
↓ ROS
[19]
Curcumin Palmitate-induced inflammation in skeletal muscle C2C12 cells 40 μM ↓ TNF-α, IL-6
↓ ROS
[20]
Curcumin TNBS-Induced Colitis Rats 100mg/kg, i.g. ↓ TLR4, NF-κB, IL-27 [21]
Curcumin dextran sulfate sodium-induced colitis mice 100 mg/kg, i.g. ↓ IL-6, IL-17, IL-23
↑ IL-10 regulating the Re-equilibration of Treg/Th17
[30]
Curcumin DSS-induced colitis mouse model 100 mg/kg, intraperitoneally injected ↓ IL-1β, IL-6, MCP-1 [35]
Curcumin DSS-induced ulcerative colitis mice model 50 mg/kg, standard diet supplemented ↓ TNF-α, IL-6 [44]
Curcumin DSS-induced acute colitis in mice 15, 30, 60 mg/kg, intraperitoneally injected ↓ TNF-α, IL-6, IL-17
↑ IL-10
[45]
Curcumin
Curcumin nanoparticles
Post-traumatic osteoarthritis mouse model 50 mg/kg, i.g.
0.07 mg of 10 μg curcumin/1 mg nanoparticles, topical application
↓ MMP-1, MMP-3, MMP-13, ADAMTS5, IL-1β, TNF-α [57]
Acid-activatable curcumin polymer Monoiodoacetic acid-induced osteoarthritis mouse model 2.5, 5 mg/kg, intramuscular injection ↓ IL-1β, TNF-α [58]
Curcumin Collagen-induced rat arthritis model 100, 200 mg/kg, oral ↓ TNF-α, IL-17, IL-1β and TGF-β [59]
Curcumin Anterior cruciate ligament transection rat model 50μL,
Intra-articular administration
↓ IL-1β, TNF-ɑ [61]
Curcumin loaded hyalurosomes Fibroblast-like synovial cells ↑ IL-10
↓ IL-6, IL-15, TNF-ɑ
[68]
Curcumin Primary rat abdominal macrophages
MSU-induced gouty arthritis rat model
1 μM
100, 150, 200 mg/kg, intraperitoneal administration
↓ IL-1β, TNF-α, NLRP3, caspase‐1 [70]
Curcumin Imiquimod-induced differentiated HaCaT cells 25, 50 µM ↓ IL-17, TNF-ɑ, IL-6, IFN-γ [80]
Curcumin Transgenic mouse model of psoriasis 40 mg/kg ↓ IFN-γ, TNF-α, IL-2, IL-12, IL-22, IL-23 [82]
Curcumin TPA-induced K14-VEGF transgenic psoriasis Topical 50mg/cm2 curcumin gel, twice daily ↓ IFN-γ [83]
Curcumin nanohydrogel imiquimod-induced psoriasis model ↓ TNF-α, iNOS [84]
Curcumin Chronic unpredictable mild stress-induced rats model 100 mg/kg, daily ↓ IL-1β, IL-6, TNF-α
↓ NF-κB activation
↓stressed-induced P2X7R/NLRP3 inflammasome axis activation
[102]
Curcumin Chronic unpredictable mild stress-induced rats model 20mg/kg, oral ↓ IL-6, TNF-α [103]
Curcumin CUMS depression model 40 mg/kg, i.p. ↓ IL-1β [104]
Curcumin ApoE-/- mice 0.1% w/w, diet addition ↓ TLR4, IL-1β, TNF-α, VCAM-1, ICAM-1, NF-κB, [122]
Mannich
Curcuminoids
TNBS-induced colitis rats model 40 mg/kg, orally ↓ NF-κB, IL-6, IL-4, TNF-α [149]
TRB-N0224 A rabbit anterior cruciate ligament transection injury-induced model of OA. 25, 50 mg/kg/day ↓IL-1β, IL-6, TNF-α, MMP-9, MMP-13 [150]
Curcumin analogue AI-44 MSU-induced THP-1 cell 3 μM ↓TNF-α, IL-1β [157]
Curcumin diglutaric acid LPS-stimulated RAW 264.7 macrophage cells 1, 5, 10, 20, and 50 µM ↓ NO, IL-6, TNF-α, iNOS, COX-2 [160]
Curcumin-galactomannoside (CGM) Acetic acid-induced colitis 250 mg/kg bwt ↓ COX-2, PGE2, iNOS, TLR4, IL-6, TNF-α [171]
Next Generation Ultrasol Curcumin (NGUC) MIA-induced OA 1100, 2200 mg/kg(20, 40 mg/kg of curcuminoids) ↓ TNF-α, IL-1β, IL-6, COMP, CRP, MMP-3, 5-LOX, COX-2, NF-κB [174]